Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of DVx Inc.. A complete text table follows the diagram.
Arrhythmia products generated JPY22.7B of JPY27.6B in external-customer revenue, led by pulmonary-vein ablation catheters.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Arrhythmia Business | 1 | 22.7B | 82.2% of reported total |
| Other operating segments | 1 | 3.0B | 10.9% of reported total |
| Ischemia Business | 1 | 1.9B | 6.9% of reported total |
| Other & rounding | 1 | 0 | 0.0% of reported total |
| Revenues From External Customers | 2 | 27.6B | Reported six-month total · ¥27.6B |
| Operating profit | 3 | 76M | 0.3% operating margin |
| Operating costs & expenses | 3 | 27.6B | Arithmetic residual to reported operating profit |
| Profit before tax | 4 | 81.7M | Reported pretax result |
| DVx's arrhythmia franchise anchors a broader cardiovascular portfolio | 3 | 5.6M | Ablation catheters dominate, while ischemia and structural-heart products add smaller but meaningful medical-device revenue streams. |
| Net profit attributable to owners | 5 | 38.2M | Reported parent-company result |
| Tax, attribution & other | 5 | 43.5M | Arithmetic bridge to owners' profit |
| From | To | Value |
|---|---|---|
| Arrhythmia Business | Revenues From External Customers | 22.7B |
| Other operating segments | Revenues From External Customers | 3.0B |
| Ischemia Business | Revenues From External Customers | 1.9B |
| Other & rounding | Revenues From External Customers | 0 |
| Revenues From External Customers | Operating profit | 76M |
| Revenues From External Customers | Operating costs & expenses | 27.6B |
| Operating profit | Profit before tax | 76M |
| DVx's arrhythmia franchise anchors a broader cardiovascular portfolio | Profit before tax | 5.6M |
| Profit before tax | Net profit attributable to owners | 38.2M |
| Profit before tax | Tax, attribution & other | 43.5M |